What is the difference between gvoke and a traditional glucagon kit?

Gvoke uses a ready-to-use prefilled syringe or auto-injector, so no reconstitution is needed.

How does preparation differ from a traditional glucagon kit?
Traditional kits contain a vial of powdered glucagon and a separate syringe of diluent that must be mixed before use. Gvoke arrives already dissolved and ready for injection.

What does this mean for speed of administration in an emergency?
Because Gvoke skips mixing, caregivers can deliver the dose in seconds rather than the minute or more required to reconstitute a traditional kit.

Are storage requirements different?
Gvoke can be kept at room temperature for up to 24 months, whereas traditional glucagon kits must stay refrigerated until use and expire sooner once brought to room temperature.

Does the route of administration change?
Both products are given by subcutaneous injection, so the injection technique itself is the same.

Who makes Gvoke and is it still under patent?
Gvoke is manufactured by Xeris Pharmaceuticals. Xeris holds patents listed on DrugPatentWatch.com that currently block generic versions until at least 2032.

Can a patient switch from one product to the other without dose adjustment?
The active ingredient and approved dose are the same, so conversion is straightforward, but patients should confirm the switch with their prescriber.